sGC Pharma Inc | www.inknowvation.com

sGC Pharma Inc
Profile last edited on: 3/11/2020 CAGE: 6LP34 UEI: JYUHP3KLLR21

Business Identifier: Therapies based on nomethiazoles, a new class of drugs

Year Founded

2007

First Award

----

Latest Award

2017

Program Status

Inactive

Popularity Index

Edit Company Profile

Is this YOUR Company?

Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached

Do you know about this Awardees?

Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Explanation

Location Information

70 Walnut Street Suite 302
Wellesley, MA 02481

(613) 791-4465

N/A

sgcpharma.com

Location: Single
Congr. District: 05
County: Norfolk

Public Profile

sGC had been developing a new class of therapeutic drugs for treatment of Alzheimers Disease and age-related cognitive disorders anchored in work undertaken by one of the firm's principals at College of Pharmacy,University of Illinois, Chicago. sGC Pharma ceased operation on/around 2016 and the project - with the same PI transferred to North Carolina firm Revivo Therapeutics founded that same year and not (to date) an SBIR-STTR involved entity in their own right. T

Extent of SBIR involvement

Phase I Awards

0 Phase II Awards

0 Conversion Rate

0.00%

Phase I Dollars

$0

Phase II Dollars

$0

Total Awarded

$0

Synopsis: Awardee Business Condition

Employee Range

1-4

Revenue Range

.5M-1M

VC funded?

Public/Private

Privately Held

Stock Info